Drug Database · Clinicians

Hyoscine butylbromide + Paracetamol

Also known as: butylscopolamine bromide (international nonproprietary name, for hyoscine butylbromide) · acetaminophen (US name, for paracetamol)

Brands (3) Dysmenos, Hyopan Plus, NavelinShow all

Analgesic/Antipyretics/Anticholinergic; Antispasmodic/Analgesic PH FDA category
Fixed-dose combination.

OTC · Over-the-counter3 PH products
Dispensing: Over-the-counter (OTC) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Hyoscine-n-butylbromide listed as hyoscine butylbromide

    Use: Gastrointestinal and genitourinary spasm (tablets) renalcarematters.com, reviewed

    Kidney dosing: Hyoscine-n-butylbromide (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    Tablets: 10 to 20 mg per dose, maximum 60 mg/day. Injection: 10 to 20 mg slowly IV, IM or SC, maximum 100 mg/day (PM).
    CrCl 30–59 mL/min
    The prescribing information gives no kidney dosing. Tablets: negligible absorption, kidney accumulation unlikely. Injection: about half of an intravenous dose is excreted unchanged in urine; use the lowest dose and watch for anticholinergic effects.
    CrCl 15–29 mL/min
    The prescribing information gives no kidney dosing. Tablets: negligible absorption, kidney accumulation unlikely. Injection: about half of an intravenous dose is excreted unchanged in urine; use the lowest dose and watch for anticholinergic effects.
    CrCl <15 mL/min (not on dialysis)
    The prescribing information gives no kidney dosing. Tablets: negligible absorption, kidney accumulation unlikely. Injection: about half of an intravenous dose is excreted unchanged in urine; use the lowest dose and watch for anticholinergic effects.
    Hemodialysis (intermittent)
    Not studied in dialysis; no dose given.
    Peritoneal dialysis
    Not studied in dialysis; no dose given.
    CRRT
    Not studied in dialysis; no dose given.
    • Dialyzable? Not stated.
    • Monitoring Anticholinergic effects: urinary retention, tachycardia, hypotension after injection (observe; emergency equipment available), raised intraocular pressure (urgent review for painful red eye). Avoid IM injection in anticoagulated patients (PM).

    From the Hyoscine-n-butylbromide monograph (renalcarematters.com, reviewed).

  • Use: Uses temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Film-coated tablet: 500 mg/10 mg
  • Tablet: 10 mg/500 mg

Registered products in the Philippines

3 products registered with the Food and Drug Administration (FDA) Philippines list Hyoscine butylbromide + Paracetamol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products3
Philippine FDA-registered products for Hyoscine butylbromide + Paracetamol
Package insert
DysmenosParacetamol + Hyoscine Butylbromide
500 mg / 10 mg Film-coated tabletAlu/PVC Blister pack x 10's (Box of 100's)
OTC
Saga Lifesciences LimitedIndia
Hexagon Pharmaceuticals
DR-XY46713
Sep 19, 2029
Hyopan PlusHyoscine butylbromide + Paracetamol
10 mg/500 mg TabletAlu/Alu Foil Strip x 10's (Box of 30's and 100's)
OTC
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises Inc.
DRP-14830
Jan 17, 2029
NavelinParacetamol + Hyoscine Butylbromide
500 mg / 10 mg Film-Coated tabletAlu/PVC Blister Pack x 10's Box of 100's
OTC
Saga Lifesciences LimitedIndia
Hexagon Pharmaceuticals
DR-XY46716
Sep 19, 2029

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .